Correction: Kinome and phosphoproteome reprogramming underlies the aberrant immune responses in critically ill COVID-19 patients
Tomonori Kaneko, Sally Ezra, Rober Abdo, Courtney Voss, Shanshan Zhong, Xuguang Liu, Owen Hovey, Marat Slessarev, Logan Robert Van Nynatten, Mingliang Ye, Douglas D. Fraser, Shawn Shun‑Cheng Li
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCOVID-19 Clinical Research Studies · Erythrocyte Function and Pathophysiology · Sepsis Diagnosis and Treatment
Correction: Clinical Proteomics (2024) 21:13 10.1186/s12014-024-09457-w
Following publication of the original article [1], the authors identified an error in the author name of Douglas D. Fraser.
The incorrect author name is: Douglas Fraser.
The correct author name is: Douglas D. Fraser.
The author group has been updated above and the original article [1] has been corrected.